Unichem Laboratories rose 3.09% to Rs 175.20 after the company said its Pithampur plant was approved by the US drug regulator after successful inspection.
The United States Food and Drug Administration (USFDA) conducted inspection at the company's Active Pharmaceutical Ingredients (APls) facility in Pithampur, Madhya Pradesh from 2 to 5 September 2019. The inspection concluded successfully without any FDA form 483. The announcement was made during market hours today, 6 September 2019.
On BSE, 4,918 shares were traded in Unichem Laboratories counter, compared to a 2-week average of 13,000 shares. The stock hit an intraday high of Rs 178.65 and an intraday low of Rs 169.80.
It hit a 52-week high of Rs 239.75 on 10 September 2018 and a 52-week low of Rs 158.35 on 31 July 2019.
Unichem Laboratories is a pharmaceutical company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
